{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:02:06Z","timestamp":1790114526692,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020052","name":"National Centre for Cell Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.isci.2025.114064","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T08:56:55Z","timestamp":1763629015000},"page":"114064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating LeishPepThera (PepA) as an immuno-therapeutic for Leishmania major infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Shweta","family":"Khandibharad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3817-8819","authenticated-orcid":false,"given":"Shailza","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.114064_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.isci.2025.114064_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1338749","article-title":"Synthetic biology for combating leishmaniasis","volume":"15","author":"Khandibharad","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.isci.2025.114064_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1995-7645(12)60084-4","article-title":"Leishmaniasis: Current status of available drugs and new potential drug targets","volume":"5","author":"Singh","year":"2012","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.isci.2025.114064_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.isci.2025.114064_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12101179","article-title":"Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis","volume":"12","author":"Lafleur","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.isci.2025.114064_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2021.03.011","article-title":"Immunotherapy in treatment of leishmaniasis","volume":"233","author":"Akbari","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.isci.2025.114064_bib7","article-title":"Advances in Leishmania Vaccines: Current Development and Future Prospects","volume":"13","author":"Ayala","year":"2024","journal-title":"Pathog. (Basel, Switzerland)"},{"key":"10.1016\/j.isci.2025.114064_bib8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/infdis\/jiaf042","article-title":"Circulating Soluble Factors and T-Cell Subsets as Immunological Predictors of Therapy Response in Human Cutaneous Leishmaniasis","volume":"232","author":"Figueiredo","year":"2025","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.isci.2025.114064_bib9","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1038\/s41467-023-42940-w","article-title":"Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acids","volume":"14","author":"Oeller","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.114064_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16020227","article-title":"The Potential Use of Peptides in the Fight against Chagas Disease and Leishmaniasis","volume":"16","author":"Berhe","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2025.114064_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamem.2021.183629","article-title":"Peptide-mediated leishmaniasis management strategy: Tachyplesin emerges as an effective anti-leishmanial peptide against Leishmania donovani","volume":"1863","author":"Kumar","year":"2021","journal-title":"Biochim. Biophys. acta. Biomembr."},{"key":"10.1016\/j.isci.2025.114064_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/msphere.00097-25","article-title":"Characterization of a novel Leishmania antigen containing a repetitive domain and its potential use as a prophylactic and therapeutic vaccine","volume":"10","author":"de Oliveira","year":"2025","journal-title":"mSphere"},{"key":"10.1016\/j.isci.2025.114064_bib13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1021\/acsptsci.4c00341","article-title":"Molecular and Immunological Properties of a Chimeric Glycosyl Hydrolase 18 Based on Immunoinformatics Approaches: A Design of a New Anti-Leishmania Vaccine","volume":"8","author":"da Cruz Freire","year":"2025","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.isci.2025.114064_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fimmu.2019.00535","article-title":"Regulation of Inflammatory Functions of Macrophages and T Lymphocytes by NFAT5","volume":"10","author":"Aramburu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib15","article-title":"TonEBP suppresses IL-10-mediated immunomodulation","volume":"6","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114064_bib16","doi-asserted-by":"crossref","first-page":"F516","DOI":"10.1152\/ajprenal.00006.2014","article-title":"Leishmania infantum-chagasi activates SHP-1 and reduces NFAT5\/TonEBP activity in the mouse kidney inner medulla","volume":"307","author":"Zhou","year":"2014","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.isci.2025.114064_bib17","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.micinf.2012.05.014","article-title":"Leishmania virulence factors: focus on the metalloprotease GP63","volume":"14","author":"Olivier","year":"2012","journal-title":"Microbes Infect."},{"key":"10.1016\/j.isci.2025.114064_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2000213","article-title":"Leishmania GP63 alters host signaling through cleavage-activated protein tyrosine phosphatases","volume":"2","author":"Gomez","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.isci.2025.114064_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fitd.2025.1450908","article-title":"Review of host-directed immunotherapy and candidate agents against leishmaniasis","volume":"6","author":"Tamir","year":"2025","journal-title":"Front. Trop. Dis."},{"key":"10.1016\/j.isci.2025.114064_bib20","article-title":"Computational System Level Approaches for Discerning Reciprocal Regulation of IL10 and IL12 in Leishmaniasis","volume":"12","author":"Khandibharad","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.isci.2025.114064_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03478-23","article-title":"Single-cell ATAC sequencing identifies sleepy macrophages during reciprocity of cytokines in L. major infection","volume":"12","author":"Khandibharad","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2025.114064_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166466","article-title":"Artificial intelligence channelizing protein-peptide interactions pipeline for host-parasite paradigm in IL-10 and IL-12 reciprocity by SHP-1","volume":"1868","author":"Khandibharad","year":"2022","journal-title":"Biochim. Biophys. acta. Mol. basis Dis."},{"key":"10.1016\/j.isci.2025.114064_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130670","article-title":"Mechanistic study of inhibitory peptides with SHP-1 in hypertonic environment for infection model","volume":"1868","author":"Khandibharad","year":"2024","journal-title":"Biochim. Biophys. acta. Gen. Subj."},{"key":"10.1016\/j.isci.2025.114064_bib24","doi-asserted-by":"crossref","DOI":"10.1128\/iai.00504-23","article-title":"IFN-\u03bb3 is induced by Leishmania donovani and can inhibit parasite growth in cell line models but not in the mouse model, while it shows a significant association with leishmaniasis in humans","volume":"92","author":"De","year":"2024","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114064_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114501","article-title":"Housing mice near vs. below thermoneutrality affects drug-induced weight loss but does not improve prediction of efficacy in humans","volume":"43","author":"Jacobsen","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.isci.2025.114064_bib26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.4049\/jimmunol.1101018","article-title":"Lymph node hypertrophy following Leishmania major infection is dependent on TLR9","volume":"188","author":"Carvalho","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13256-023-03852-x","article-title":"Pediatric lymphatic leishmaniasis: a case report","volume":"17","author":"Kindie","year":"2023","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.isci.2025.114064_bib28","article-title":"Hepatomegaly Associated with Non-Obstructive Sinusoidal Dilation in Experimental Visceral Leishmaniasis","volume":"10","author":"Maeda","year":"2021","journal-title":"Pathog. (Basel, Switzerland)"},{"key":"10.1016\/j.isci.2025.114064_bib29","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1128\/IAI.71.4.2041-2046.2003","article-title":"Different genetic control of cutaneous and visceral disease after Leishmania major infection in mice","volume":"71","author":"Vladimirov","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114064_bib30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3389\/fimmu.2019.01083","article-title":"Novel Loci Controlling Parasite Load in Organs of Mice Infected With Leishmania major, Their Interactions and Sex Influence","volume":"10","author":"Kobets","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib31","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1084\/jem.20171389","article-title":"Mannose receptor high, M2 dermal macrophages mediate nonhealing Leishmania major infection in a Th1 immune environment","volume":"215","author":"Lee","year":"2018","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2025.114064_bib32","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3442","article-title":"Quantification of Nitric Oxide and Reactive Oxygen Species in Leishmania-infected J774A.1 Macrophages as a Response to the in vitro treatment with a Natural Product Compound","volume":"9","author":"Karampetsou","year":"2019","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.isci.2025.114064_bib33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/AAC.01014-09","article-title":"Miltefosine efficiently eliminates Leishmania major amastigotes from infected murine dendritic cells without altering their immune functions","volume":"54","author":"Griewank","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.114064_bib34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/scipharm91040054","article-title":"Monitoring Cutaneous Leishmaniasis Lesions in Mice Undergoing Topical Miltefosine Treatment","volume":"91","author":"Neira","year":"2023","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.isci.2025.114064_bib35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.intimp.2012.03.016","article-title":"Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL\/6 mice","volume":"13","author":"Ponte","year":"2012","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.isci.2025.114064_bib36","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.168.11.5771","article-title":"The role of IL-12 in maintaining resistance to Leishmania major","volume":"168","author":"Park","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib37","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S1286-4579(00)01340-X","article-title":"Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice","volume":"2","author":"Lemos de Souza","year":"2000","journal-title":"Microbes Infect."},{"key":"10.1016\/j.isci.2025.114064_bib38","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1002\/1521-4141(200212)32:12<3556::AID-IMMU3556>3.0.CO;2-Q","article-title":"The TGF-beta response to Leishmania chagasi in the absence of IL-12","volume":"32","author":"Wilson","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib39","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.4049\/jimmunol.180.6.4090","article-title":"IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL\/6 mice","volume":"180","author":"Anderson","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib40","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.4049\/jimmunol.174.8.4916","article-title":"Prevention of relapse after chemotherapy in a chronic intracellular infection: mechanisms in experimental visceral leishmaniasis","volume":"174","author":"Murray","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2024.102987","article-title":"Immunomodulation by Leishmania parasites: Potential for controlling other diseases","volume":"104","author":"Goto","year":"2025","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.isci.2025.114064_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.166.2.1141","article-title":"The role of IL-10 in promoting disease progression in leishmaniasis","volume":"166","author":"Kane","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib43","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1006\/cyto.2000.0694","article-title":"IL-10 and IL-12 are the main regulatory cytokines in visceral leishmaniasis","volume":"12","author":"Bacellar","year":"2000","journal-title":"Cytokine"},{"key":"10.1016\/j.isci.2025.114064_bib44","doi-asserted-by":"crossref","first-page":"F362","DOI":"10.1152\/ajprenal.00218.2013","article-title":"High NaCl-induced inhibition of PTG contributes to activation of NFAT5 through attenuation of the negative effect of SHP-1","volume":"305","author":"Zhou","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.isci.2025.114064_bib45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3892\/br.2016.639","article-title":"Cell-penetrating peptides: Possible transduction mechanisms and therapeutic applications","volume":"4","author":"Guo","year":"2016","journal-title":"Biomed. Rep."},{"key":"10.1016\/j.isci.2025.114064_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.advenzreg.2011.09.003","article-title":"Regulation of proliferation, survival, differentiation, and activation by the Signaling Platform for SHP-1 phosphatase","volume":"52","author":"Kawakami","year":"2012","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.isci.2025.114064_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-15455-5","article-title":"A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responses","volume":"12","author":"Agrez","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114064_bib48","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0264-410X(98)00363-6","article-title":"Long-term protection of mice against Leishmania major with a synthetic peptide vaccine","volume":"17","author":"Spitzer","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.isci.2025.114064_bib49","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.3390\/pharmaceutics14112528","article-title":"Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis","volume":"14","author":"El-Dirany","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.isci.2025.114064_bib50","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.05349-11","article-title":"Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo","volume":"56","author":"Erfe","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.isci.2025.114064_bib51","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300679","article-title":"Targeting peptide based therapeutics: Integrated computational and experimental studies of autophagic regulation in host-parasite interaction","volume":"19","author":"Guhe","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.isci.2025.114064_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00124-21","article-title":"Hypoxia-Inducible Factor Signaling in Macrophages Promotes Lymphangiogenesis in Leishmania major Infection","volume":"89","author":"Bowlin","year":"2021","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114064_bib53","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2334-12-75","article-title":"Macrophages participate in host protection and the disease pathology associated with Leishmania braziliensis infection","volume":"12","author":"Giudice","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.isci.2025.114064_bib54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1462-5822.2000.00070.x","article-title":"Macrophage subsets harbouring Leishmania donovani in spleens of infected BALB\/c mice: localization and characterization","volume":"2","author":"Lang","year":"2000","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.isci.2025.114064_bib55","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41598-020-79068-6","article-title":"Leishmania donovani infection suppresses Allograft Inflammatory Factor-1 in monocytes and macrophages to inhibit inflammatory responses","volume":"11","author":"da Silva","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.isci.2025.114064_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.00001","article-title":"Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major","volume":"9","author":"Hu","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib57","article-title":"Inflammatory CD11b(+) Macrophages Produce BAFF in Spleen of Mice Infected with Leishmania donovani","volume":"13","author":"Nagai","year":"2024","journal-title":"Pathog. (Basel, Switzerland)"},{"key":"10.1016\/j.isci.2025.114064_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01126-22","article-title":"Leishmania major Strain-Dependent Macrophage Activation Contributes to Pathogenicity in the Absence of Lymphocytes","volume":"10","author":"Alshaweesh","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.isci.2025.114064_bib59","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.3389\/fimmu.2018.02529","article-title":"Macrophage Polarization in Leishmaniasis: Broadening Horizons","volume":"9","author":"Tomiotto-Pellissier","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.isci.2025.114064_bib60","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5596876","article-title":"Macrophage Polarization in the Skin Lesion Caused by Neotropical Species of Leishmania sp","volume":"2021","author":"Sandoval Pacheco","year":"2021","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.isci.2025.114064_bib61","article-title":"Leishmaniasis: Immune Cells Crosstalk in Macrophage Polarization","volume":"8","author":"Almeida","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.isci.2025.114064_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052449","article-title":"Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation","volume":"8","author":"Pena","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.114064_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073607","article-title":"Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte\/Macrophage THP-1 Cell Line","volume":"23","author":"Avolio","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.114064_bib64","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1128\/IAI.68.12.6561-6566.2000","article-title":"Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice","volume":"68","author":"Nicolas","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114064_bib65","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1128\/IAI.71.12.6830-6834.2003","article-title":"The site of Leishmania major infection determines disease severity and immune responses","volume":"71","author":"Baldwin","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.isci.2025.114064_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006123","article-title":"Human Neutrophil Peptide 1 as immunotherapeutic agent against Leishmania infected BALB\/c mice","volume":"11","author":"Abdossamadi","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.isci.2025.114064_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-1759(99)00085-X","article-title":"A method for the isolation and analysis of leucocytic cells from Leishmanial ear lesions in mice","volume":"228","author":"DeKrey","year":"1999","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.isci.2025.114064_bib68","first-page":"576","article-title":"Parasite Burden Measurement in the Leishmania major Infected Mice by Using the Direct Fluorescent Microscopy, Limiting Dilution Assay, and Real-Time PCR Analysis. Iran","volume":"15","author":"Haghdoust","year":"2020","journal-title":"J. Parasitol."},{"key":"10.1016\/j.isci.2025.114064_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ani14040605","article-title":"Enhancing Control of Leishmania infantum Infection: A Multi-Epitope Nanovaccine for Durable T-Cell Immunity","volume":"14","author":"Hurtado-Morillas","year":"2024","journal-title":"Animals"},{"key":"10.1016\/j.isci.2025.114064_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165978","article-title":"Evolutionary artificial intelligence based peptide discoveries for effective Covid-19 therapeutics","volume":"1867","author":"Kabra","year":"2021","journal-title":"Biochim. Biophys. acta. Mol. basis Dis."},{"key":"10.1016\/j.isci.2025.114064_bib71","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1251\/bpo92","article-title":"Screening of Compounds Toxicity against Human Monocytic cell line-THP-1 by Flow Cytometry","volume":"6","author":"Pick","year":"2004","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.isci.2025.114064_bib72","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3410","article-title":"In vitro Screening of Antileishmanial Activity of Natural Product Compounds: Determination of IC(50), CC(50) and SI Values","volume":"9","author":"Koutsoni","year":"2019","journal-title":"Bio. Protoc."},{"key":"10.1016\/j.isci.2025.114064_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101923","article-title":"An optimized protocol for the isolation of rare stromal cell populations from the mouse spleen","volume":"3","author":"Alexandre","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.isci.2025.114064_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100539","article-title":"Collecting mouse livers for transcriptome analysis of daily rhythms","volume":"2","author":"Mortimer","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.isci.2025.114064_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101668","article-title":"Optimized protocol to isolate primary mouse peritoneal macrophage metabolites","volume":"3","author":"De Jesus","year":"2022","journal-title":"STAR Protoc."},{"key":"10.1016\/j.isci.2025.114064_bib76","article-title":"Immunometabolic Circuits in Infection for Advancing Host Directed Therapies","volume":"211","author":"Khandibharad","year":"2024","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.isci.2025.114064_bib77","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.3633","article-title":"RNA Extraction from Ears and Draining Lymph Nodes of Mice Infected with Leishmania amazonensis","volume":"10","author":"Giraud","year":"2020","journal-title":"Bio. Protoc."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225023259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225023259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T01:24:32Z","timestamp":1783473872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225023259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":77,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2589004225023259"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.114064","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating LeishPepThera (PepA) as an immuno-therapeutic for Leishmania major infection","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.114064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114064"}}